Skip to content 
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California. more
| Time Frame | QDEL | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -0.53% | 0.81% | 0.49% |
| 1-Month Return | -27.86% | 1.2% | 1.02% |
| 3-Month Return | 12.48% | 3.24% | 3.34% |
| 6-Month Return | -11.72% | 14.99% | 7.04% |
| 1-Year Return | -43.64% | 7.42% | 11.68% |
| 3-Year Return | -73.68% | 20.71% | 71.63% |
| 5-Year Return | -87.07% | 37.45% | 75.56% |
| 10-Year Return | 66.74% | 138.53% | 257.55% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 1.70B | 3.27B | 3.00B | 2.78B | 2.73B | [{"date":"2021-12-31","value":52.01,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":91.79,"profit":true},{"date":"2024-12-31","value":85.21,"profit":true},{"date":"2025-12-31","value":83.59,"profit":true}] |
| Cost of Revenue | 420.30M | 1.33B | 1.50B | 1.50B | 1.46B | [{"date":"2021-12-31","value":28.01,"profit":true},{"date":"2022-12-31","value":88.61,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":99.71,"profit":true},{"date":"2025-12-31","value":97.02,"profit":true}] |
| Gross Profit | 1.28B | 1.94B | 1.50B | 1.29B | 1.27B | [{"date":"2021-12-31","value":66.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.32,"profit":true},{"date":"2024-12-31","value":66.44,"profit":true},{"date":"2025-12-31","value":65.81,"profit":true}] |
| Gross Margin | 75.26% | 59.28% | 49.94% | 46.23% | 46.67% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.78,"profit":true},{"date":"2023-12-31","value":66.36,"profit":true},{"date":"2024-12-31","value":61.43,"profit":true},{"date":"2025-12-31","value":62.02,"profit":true}] |
| Operating Expenses | 372.30M | 1.09B | 1.36B | 3.25B | 2.19B | [{"date":"2021-12-31","value":11.46,"profit":true},{"date":"2022-12-31","value":33.64,"profit":true},{"date":"2023-12-31","value":41.82,"profit":true},{"date":"2024-12-31","value":100,"profit":true},{"date":"2025-12-31","value":67.54,"profit":true}] |
| Operating Income | 906.00M | 843.70M | 139.10M | (1.96B) | (919.20M) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.12,"profit":true},{"date":"2023-12-31","value":15.35,"profit":true},{"date":"2024-12-31","value":-216.43,"profit":false},{"date":"2025-12-31","value":-101.46,"profit":false}] |
| Total Non-Operating Income/Expense | (11.41M) | (183.50M) | (344.90M) | (359.50M) | - | [{"date":"2021-12-31","value":-1140600000,"profit":false},{"date":"2022-12-31","value":-18350000000,"profit":false},{"date":"2023-12-31","value":-34490000000,"profit":false},{"date":"2024-12-31","value":-35950000000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 900.30M | 735.90M | (29.10M) | (2.13B) | (1.11B) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":81.74,"profit":true},{"date":"2023-12-31","value":-3.23,"profit":false},{"date":"2024-12-31","value":-236.75,"profit":false},{"date":"2025-12-31","value":-123.04,"profit":false}] |
| Income Taxes | 196.10M | 187.20M | (19.00M) | (79.50M) | 24.10M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":95.46,"profit":true},{"date":"2023-12-31","value":-9.69,"profit":false},{"date":"2024-12-31","value":-40.54,"profit":false},{"date":"2025-12-31","value":12.29,"profit":true}] |
| Income After Taxes | 704.20M | 548.70M | (10.10M) | (2.05B) | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.92,"profit":true},{"date":"2023-12-31","value":-1.43,"profit":false},{"date":"2024-12-31","value":-291.39,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 704.23M | 548.70M | (10.10M) | (2.05B) | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.92,"profit":true},{"date":"2023-12-31","value":-1.43,"profit":false},{"date":"2024-12-31","value":-291.38,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 704.20M | 548.70M | (10.10M) | (2.05B) | (1.13B) | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":77.92,"profit":true},{"date":"2023-12-31","value":-1.43,"profit":false},{"date":"2024-12-31","value":-291.39,"profit":false},{"date":"2025-12-31","value":-160.72,"profit":false}] |
| EPS (Diluted) | 17.78 | 17.61 | 4.13 | 1.85 | 2.12 | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":99.04,"profit":true},{"date":"2023-12-31","value":23.23,"profit":true},{"date":"2024-12-31","value":10.4,"profit":true},{"date":"2025-12-31","value":11.92,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| QDEL | |
|---|---|
| Cash Ratio | 0.21 |
| Current Ratio | 1.50 |
| Quick Ratio | 0.90 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| QDEL | |
|---|---|
| ROA (LTM) | 0.56% |
| ROE (LTM) | -46.15% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| QDEL | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.67 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.33 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| QDEL | |
|---|---|
| Trailing PE | NM |
| Forward PE | 8.91 |
| P/S (TTM) | 0.60 |
| P/B | 0.83 |
| Price/FCF | NM |
| EV/R | 1.55 |
| EV/Ebitda | 22.78 |
| PEG | 7.19 |
Quidel Corporation (QDEL) share price today is $22.94
Yes, Indians can buy shares of Quidel Corporation (QDEL) on Vested. To buy
Yes, you can purchase fractional shares of Quidel Corporation (QDEL) via the Vested app. You can start investing in Quidel Corporation (QDEL) with a minimum investment of $1.
You can invest in shares of Quidel Corporation (QDEL) via Vested in three simple steps:
The 52-week high price of Quidel Corporation (QDEL) is $42.2. The 52-week low price of Quidel Corporation (QDEL) is $19.5.
The price-to-earnings (P/E) ratio of Quidel Corporation (QDEL) is
The price-to-book (P/B) ratio of Quidel Corporation (QDEL) is 0.83
The dividend yield of Quidel Corporation (QDEL) is 0.00%
The market capitalization of Quidel Corporation (QDEL) is $1.60B
The stock symbol (or ticker) of Quidel Corporation is QDEL
Consider the share price of Quidel Corporation as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Quidel Corporation has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in Quidel Corporation shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Quidel Corporation stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of Quidel Corporation and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Quidel Corporation stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
